⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OPK News
Opko Health Inc.
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
globenewswire.com
OPK
OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
globenewswire.com
OPK
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
globenewswire.com
OPK
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
prnewswire.com
LH
OPK
LH
OPK